Sculptor Capital LP Makes New $2.49 Million Investment in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Sculptor Capital LP bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 250,000 shares of the company’s stock, valued at approximately $2,490,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in OACC. Lighthouse Investment Partners LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at approximately $3,039,000. K2 Principal Fund L.P. purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth $1,945,000. AQR Arbitrage LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth $19,743,000. Finally, Shaolin Capital Management LLC purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at $5,478,000.

Oaktree Acquisition Corp. III Life Sciences Trading Down 0.1%

Shares of OACC stock opened at $10.45 on Friday. The firm’s fifty day simple moving average is $10.23. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.95 and a 12 month high of $10.85.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.